Adversity Index for Clinical Trials: An Inclusive Approach for Analysis of Safety Data

06/01/2018
by   Sharayu Paranjpe, et al.
0

This paper proposes a new method for analysis of adverse event data in clinical trials. The method is illustrated by application to data on 4 phase III clinical trials, two on breast cancer and two on diabetes mellitus.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
09/14/2023

Text Classification of Cancer Clinical Trial Eligibility Criteria

Automatic identification of clinical trials for which a patient is eligi...
research
06/27/2023

Multivariate Rank-Based Analysis of Multiple Endpoints in Clinical Trials: A Global Test Approach

Clinical trials often involve the assessment of multiple endpoints to co...
research
01/20/2021

Bayesian Meta-analysis of Rare Events with Non-ignorable Missing Data

Meta-analysis is a powerful tool for drug safety assessment by synthesiz...
research
05/17/2023

Utilising high-dimensional data in randomised clinical trials: a review of methods and practice

Introduction Even in effectively conducted randomised trials, the prob...
research
06/19/2020

A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments

Clinical trials are the basis of Evidence-Based Medicine. Trial results ...
research
02/21/2019

Towards More Flexible False Positive Control in Phase III Randomized Clinical Trials

Phase III randomized clinical trials play a monumentally critical role i...

Please sign up or login with your details

Forgot password? Click here to reset